Development of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative representative of a severe respiratory illness resulted in widespread human infections and deaths in nearly all of the countries since late 2019. There is no therapeutic FDA-approved drug against SARS-CoV-2 infection, alth...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Biomol Struct Dyn
Hauptverfasser: Babadaei, Mohammad Mahdi Nejadi, Hasan, Anwarul, Vahdani, Yasaman, Bloukh, Samir Haj, Sharifi, Majid, Kachooei, Ehsan, Haghighat, Setareh, Falahati, Mojtaba
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis 2020
Schlagworte:
Review Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7256352/
https://ncbi.nlm.nih.gov/pubmed/32397906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1767210
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge